217 related articles for article (PubMed ID: 32770836)
1. Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected Cells.
Fergusson JR; Wallace Z; Connolly MM; Woon AP; Suckling RJ; Hine DW; Barber C; Bunjobpol W; Choi BS; Crespillo S; Dembek M; Dieckmann N; Donoso J; Godinho LF; Grant T; Howe D; McCully ML; Perot C; Sarkar A; Seifert FU; Singh PK; Stegmann KA; Turner B; Verma A; Walker A; Leonard S; Maini MK; Wiederhold K; Dorrell L; Simmons R; Knox A
Hepatology; 2020 Nov; 72(5):1528-1540. PubMed ID: 32770836
[TBL] [Abstract][Full Text] [Related]
2. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines.
Gehring AJ; Xue SA; Ho ZZ; Teoh D; Ruedl C; Chia A; Koh S; Lim SG; Maini MK; Stauss H; Bertoletti A
J Hepatol; 2011 Jul; 55(1):103-10. PubMed ID: 21145860
[TBL] [Abstract][Full Text] [Related]
3. T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes.
Bohne F; Chmielewski M; Ebert G; Wiegmann K; Kürschner T; Schulze A; Urban S; Krönke M; Abken H; Protzer U
Gastroenterology; 2008 Jan; 134(1):239-47. PubMed ID: 18166356
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.
de Beijer MTA; Jansen DTSL; Dou Y; van Esch WJE; Mok JY; Maas MJP; Brasser G; de Man RA; Woltman AM; Buschow SI
J Virol; 2020 Mar; 94(7):. PubMed ID: 31852786
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.
Wang Z; Zhu K; Bai W; Jia B; Hu H; Zhou D; Zhang X; Zhang X; Xie Y; Bourgine MM; Michel ML; Lan K; Deng Q
J Virol; 2014 Mar; 88(5):3004-15. PubMed ID: 24371056
[TBL] [Abstract][Full Text] [Related]
6. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
[TBL] [Abstract][Full Text] [Related]
7. T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice.
Quitt O; Luo S; Meyer M; Xie Z; Golsaz-Shirazi F; Loffredo-Verde E; Festag J; Bockmann JH; Zhao L; Stadler D; Chou WM; Tedjokusumo R; Wettengel JM; Ko C; Noeßner E; Bulbuc N; Shokri F; Lüttgau S; Heikenwälder M; Bohne F; Moldenhauer G; Momburg F; Protzer U
J Hepatol; 2021 Nov; 75(5):1058-1071. PubMed ID: 34171437
[TBL] [Abstract][Full Text] [Related]
8. Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3.
Koh S; Kah J; Tham CYL; Yang N; Ceccarello E; Chia A; Chen M; Khakpoor A; Pavesi A; Tan AT; Dandri M; Bertoletti A
Gastroenterology; 2018 Jul; 155(1):180-193.e6. PubMed ID: 29550589
[TBL] [Abstract][Full Text] [Related]
9. Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.
Le Bert N; Gill US; Hong M; Kunasegaran K; Tan DZM; Ahmad R; Cheng Y; Dutertre CA; Heinecke A; Rivino L; Tan A; Hansi NK; Zhang M; Xi S; Chong Y; Pflanz S; Newell EW; Kennedy PTF; Bertoletti A
Gastroenterology; 2020 Aug; 159(2):652-664. PubMed ID: 32302614
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
Khakpoor A; Ni Y; Chen A; Ho ZZ; Oei V; Yang N; Giri R; Chow JX; Tan AT; Kennedy PT; Maini M; Urban S; Bertoletti A
J Virol; 2019 Feb; 93(4):. PubMed ID: 30518652
[TBL] [Abstract][Full Text] [Related]
11. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
[TBL] [Abstract][Full Text] [Related]
12. T cell receptor grafting allows virological control of Hepatitis B virus infection.
Wisskirchen K; Kah J; Malo A; Asen T; Volz T; Allweiss L; Wettengel JM; Lütgehetmann M; Urban S; Bauer T; Dandri M; Protzer U
J Clin Invest; 2019 Apr; 129(7):2932-2945. PubMed ID: 31039136
[TBL] [Abstract][Full Text] [Related]
13. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
[TBL] [Abstract][Full Text] [Related]
14. Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.
Wisskirchen K; Metzger K; Schreiber S; Asen T; Weigand L; Dargel C; Witter K; Kieback E; Sprinzl MF; Uckert W; Schiemann M; Busch DH; Krackhardt AM; Protzer U
PLoS One; 2017; 12(8):e0182936. PubMed ID: 28792537
[TBL] [Abstract][Full Text] [Related]
15. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
[TBL] [Abstract][Full Text] [Related]
17. TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
Boni C; Vecchi A; Rossi M; Laccabue D; Giuberti T; Alfieri A; Lampertico P; Grossi G; Facchetti F; Brunetto MR; Coco B; Cavallone D; Mangia A; Santoro R; Piazzolla V; Lau A; Gaggar A; Subramanian GM; Ferrari C
Gastroenterology; 2018 May; 154(6):1764-1777.e7. PubMed ID: 29378197
[TBL] [Abstract][Full Text] [Related]
18. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.
Chung MK; Yoon H; Min SS; Lee HG; Kim YJ; Lee TG; Lim JS; Kim CM; Park SN
J Immunother; 1999 Jul; 22(4):279-87. PubMed ID: 10404429
[TBL] [Abstract][Full Text] [Related]
19. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
[TBL] [Abstract][Full Text] [Related]
20. Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes.
Godon O; Evlachev A; Bourgine M; Meritet JF; Martin P; Inchauspe G; Michel ML
Vaccine; 2015 Aug; 33(36):4548-53. PubMed ID: 26209840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
